Vaccine provides protection against particular diseases by improving immunity. Vaccines are the biological preparations of weakened or killed microorganism, its surface proteins or its toxins.
The global paediatric vaccine market is expected to grow at a healthy CAGR in next few years.
Increase in growth would be primarily attributed to improved understanding of immunology, which has resulted in launch of new vaccines products. Technological breakthrough has led to development of new vaccine class such as DNA vaccines, vector vaccines, intranasal vaccines, mucosal vaccines and others.
However, manufacturing complexity and stringent regulatory compliance are the factors that hinder the market growth. Refusal to immunization and vaccines shortages are other restraints for this market.
In 2017, the global Paediatric Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Paediatric Vaccine market based on company, product type, application and key regions.
This report studies the global market size of Paediatric Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Paediatric Vaccine in these regions.
This research report categorizes the global Paediatric Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
The various contributors involved in the value chain of Paediatric Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Paediatric Vaccine include
GlaxoSmithCline
Merck
Sanofi
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly
Pfizer
F. Hoffmann-La Roche
Novo Nordisk
Market Size Split by Type
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
MMR
Pediatric Hormones
HIB
Allergy and Respiratory vaccines
Other Pediatric vaccines
Market Size Split by Application
Age (0-3)
Age (3-12)
Age Above 12
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Paediatric Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Paediatric Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Paediatric Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Paediatric Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Paediatric Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Paediatric Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Paediatric Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The global paediatric vaccine market is expected to grow at a healthy CAGR in next few years.
Increase in growth would be primarily attributed to improved understanding of immunology, which has resulted in launch of new vaccines products. Technological breakthrough has led to development of new vaccine class such as DNA vaccines, vector vaccines, intranasal vaccines, mucosal vaccines and others.
However, manufacturing complexity and stringent regulatory compliance are the factors that hinder the market growth. Refusal to immunization and vaccines shortages are other restraints for this market.
In 2017, the global Paediatric Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Paediatric Vaccine market based on company, product type, application and key regions.
This report studies the global market size of Paediatric Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Paediatric Vaccine in these regions.
This research report categorizes the global Paediatric Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
The various contributors involved in the value chain of Paediatric Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Paediatric Vaccine include
GlaxoSmithCline
Merck
Sanofi
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly
Pfizer
F. Hoffmann-La Roche
Novo Nordisk
Market Size Split by Type
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
MMR
Pediatric Hormones
HIB
Allergy and Respiratory vaccines
Other Pediatric vaccines
Market Size Split by Application
Age (0-3)
Age (3-12)
Age Above 12
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Paediatric Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Paediatric Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Paediatric Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Paediatric Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Paediatric Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Paediatric Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Paediatric Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Paediatric Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Paediatric Vaccine Market Size Growth Rate by Type
1.4.2 Pneumococcal
1.4.3 Varicella
1.4.4 Combinations
1.4.5 Poliovirus
1.4.6 Hepatitis
1.4.7 MMR
1.4.8 Pediatric Hormones
1.4.9 HIB
1.4.10 Allergy and Respiratory vaccines
1.4.11 Other Pediatric vaccines
1.5 Market by Application
1.5.1 Global Paediatric Vaccine Market Size Growth Rate by Application
1.5.2 Age (0-3)
1.5.3 Age (3-12)
1.5.4 Age Above 12
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Paediatric Vaccine Market Size
2.1.1 Global Paediatric Vaccine Revenue 2016-2025
2.1.2 Global Paediatric Vaccine Sales 2016-2025
2.2 Paediatric Vaccine Growth Rate by Regions
2.2.1 Global Paediatric Vaccine Sales by Regions
2.2.2 Global Paediatric Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Paediatric Vaccine Sales by Manufacturers
3.1.1 Paediatric Vaccine Sales by Manufacturers
3.1.2 Paediatric Vaccine Sales Market Share by Manufacturers
3.1.3 Global Paediatric Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Paediatric Vaccine Revenue by Manufacturers
3.2.1 Paediatric Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Paediatric Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Paediatric Vaccine Price by Manufacturers
3.4 Paediatric Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Paediatric Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Paediatric Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Paediatric Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Paediatric Vaccine Sales by Type
4.2 Global Paediatric Vaccine Revenue by Type
4.3 Paediatric Vaccine Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Paediatric Vaccine Breakdown Data by Application
6 North America
6.1 North America Paediatric Vaccine by Countries
6.1.1 North America Paediatric Vaccine Sales by Countries
6.1.2 North America Paediatric Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Paediatric Vaccine by Type
6.3 North America Paediatric Vaccine by Application
6.4 North America Paediatric Vaccine by Company
7 Europe
7.1 Europe Paediatric Vaccine by Countries
7.1.1 Europe Paediatric Vaccine Sales by Countries
7.1.2 Europe Paediatric Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Paediatric Vaccine by Type
7.3 Europe Paediatric Vaccine by Application
7.4 Europe Paediatric Vaccine by Company
8 Asia Pacific
8.1 Asia Pacific Paediatric Vaccine by Countries
8.1.1 Asia Pacific Paediatric Vaccine Sales by Countries
8.1.2 Asia Pacific Paediatric Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Paediatric Vaccine by Type
8.3 Asia Pacific Paediatric Vaccine by Application
8.4 Asia Pacific Paediatric Vaccine by Company
9 Central & South America
9.1 Central & South America Paediatric Vaccine by Countries
9.1.1 Central & South America Paediatric Vaccine Sales by Countries
9.1.2 Central & South America Paediatric Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Paediatric Vaccine by Type
9.3 Central & South America Paediatric Vaccine by Application
9.4 Central & South America Paediatric Vaccine by Company
10 Middle East and Africa
10.1 Middle East and Africa Paediatric Vaccine by Countries
10.1.1 Middle East and Africa Paediatric Vaccine Sales by Countries
10.1.2 Middle East and Africa Paediatric Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Paediatric Vaccine by Type
10.3 Middle East and Africa Paediatric Vaccine by Application
10.4 Middle East and Africa Paediatric Vaccine by Company
11 Company Profiles
11.1 GlaxoSmithCline
11.1.1 GlaxoSmithCline Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.1.4 Paediatric Vaccine Product Description
11.1.5 Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.2.4 Paediatric Vaccine Product Description
11.2.5 Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.3.4 Paediatric Vaccine Product Description
11.3.5 Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.4.4 Paediatric Vaccine Product Description
11.4.5 Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.5.4 Paediatric Vaccine Product Description
11.5.5 Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.6.4 Paediatric Vaccine Product Description
11.6.5 Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.7.4 Paediatric Vaccine Product Description
11.7.5 Recent Development
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.8.4 Paediatric Vaccine Product Description
11.8.5 Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.9.4 Paediatric Vaccine Product Description
11.9.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Paediatric Vaccine Raw Material
13.1.2 Paediatric Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
1 Study Coverage
1.1 Paediatric Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Paediatric Vaccine Market Size Growth Rate by Type
1.4.2 Pneumococcal
1.4.3 Varicella
1.4.4 Combinations
1.4.5 Poliovirus
1.4.6 Hepatitis
1.4.7 MMR
1.4.8 Pediatric Hormones
1.4.9 HIB
1.4.10 Allergy and Respiratory vaccines
1.4.11 Other Pediatric vaccines
1.5 Market by Application
1.5.1 Global Paediatric Vaccine Market Size Growth Rate by Application
1.5.2 Age (0-3)
1.5.3 Age (3-12)
1.5.4 Age Above 12
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Paediatric Vaccine Market Size
2.1.1 Global Paediatric Vaccine Revenue 2016-2025
2.1.2 Global Paediatric Vaccine Sales 2016-2025
2.2 Paediatric Vaccine Growth Rate by Regions
2.2.1 Global Paediatric Vaccine Sales by Regions
2.2.2 Global Paediatric Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Paediatric Vaccine Sales by Manufacturers
3.1.1 Paediatric Vaccine Sales by Manufacturers
3.1.2 Paediatric Vaccine Sales Market Share by Manufacturers
3.1.3 Global Paediatric Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Paediatric Vaccine Revenue by Manufacturers
3.2.1 Paediatric Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Paediatric Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Paediatric Vaccine Price by Manufacturers
3.4 Paediatric Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Paediatric Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Paediatric Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Paediatric Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Paediatric Vaccine Sales by Type
4.2 Global Paediatric Vaccine Revenue by Type
4.3 Paediatric Vaccine Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Paediatric Vaccine Breakdown Data by Application
6 North America
6.1 North America Paediatric Vaccine by Countries
6.1.1 North America Paediatric Vaccine Sales by Countries
6.1.2 North America Paediatric Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Paediatric Vaccine by Type
6.3 North America Paediatric Vaccine by Application
6.4 North America Paediatric Vaccine by Company
7 Europe
7.1 Europe Paediatric Vaccine by Countries
7.1.1 Europe Paediatric Vaccine Sales by Countries
7.1.2 Europe Paediatric Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Paediatric Vaccine by Type
7.3 Europe Paediatric Vaccine by Application
7.4 Europe Paediatric Vaccine by Company
8 Asia Pacific
8.1 Asia Pacific Paediatric Vaccine by Countries
8.1.1 Asia Pacific Paediatric Vaccine Sales by Countries
8.1.2 Asia Pacific Paediatric Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Paediatric Vaccine by Type
8.3 Asia Pacific Paediatric Vaccine by Application
8.4 Asia Pacific Paediatric Vaccine by Company
9 Central & South America
9.1 Central & South America Paediatric Vaccine by Countries
9.1.1 Central & South America Paediatric Vaccine Sales by Countries
9.1.2 Central & South America Paediatric Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Paediatric Vaccine by Type
9.3 Central & South America Paediatric Vaccine by Application
9.4 Central & South America Paediatric Vaccine by Company
10 Middle East and Africa
10.1 Middle East and Africa Paediatric Vaccine by Countries
10.1.1 Middle East and Africa Paediatric Vaccine Sales by Countries
10.1.2 Middle East and Africa Paediatric Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Paediatric Vaccine by Type
10.3 Middle East and Africa Paediatric Vaccine by Application
10.4 Middle East and Africa Paediatric Vaccine by Company
11 Company Profiles
11.1 GlaxoSmithCline
11.1.1 GlaxoSmithCline Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.1.4 Paediatric Vaccine Product Description
11.1.5 Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.2.4 Paediatric Vaccine Product Description
11.2.5 Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.3.4 Paediatric Vaccine Product Description
11.3.5 Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.4.4 Paediatric Vaccine Product Description
11.4.5 Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.5.4 Paediatric Vaccine Product Description
11.5.5 Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.6.4 Paediatric Vaccine Product Description
11.6.5 Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.7.4 Paediatric Vaccine Product Description
11.7.5 Recent Development
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.8.4 Paediatric Vaccine Product Description
11.8.5 Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Paediatric Vaccine
11.9.4 Paediatric Vaccine Product Description
11.9.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Paediatric Vaccine Raw Material
13.1.2 Paediatric Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.